Market revenue in 2023 | USD 55.8 million |
Market revenue in 2030 | USD 110.8 million |
Growth rate | 10.3% (CAGR from 2023 to 2030) |
Largest segment | Biocompatibility tests |
Fastest growing segment | Chemistry Test |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing, Package Validation |
Key market players worldwide | SGS AG, Labcorp Holdings Inc, Sotera Health Co Ordinary Shares, Charles River Laboratories International Inc, NAMSA, Eurofins Scientific SE, Intertek Group PLC, Wuxi AppTec Co Ltd, TUV SUD, Element Materials Technology, Pace Analytical Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical device testing services market will help companies and investors design strategic landscapes.
Biocompatibility tests was the largest segment with a revenue share of 49.64% in 2023. Horizon Databook has segmented the Japan medical device testing services market based on biocompatibility tests, chemistry test, microbiology & sterility testing, package validation covering the revenue growth of each sub-segment from 2018 to 2030.
The medical device testing services market in Japan is anticipated to grow at 8.92% due to its growing medical devices industry, rapid technological advancements, increasing demand for outsourcing services, and rising healthcare expenditure. In addition, the expanding service portfolio for preventive care is boosting the requirement for medical device testing services.
Moreover, the market movement in the country has led to a large number of medical device manufacturers preferring medical device testing services to develop new products, which is expected to contribute to market growth.
In addition, the presence of a stringent regulatory framework & standards for medical device manufacturing is leading to an increase in overall costs. Thus, an increase in the need to maintain standards and simultaneously curb healthcare expenditure is anticipated to drive the market in this region. Such efforts are expected to boost the market over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan medical device testing services market , including forecasts for subscribers. This country databook contains high-level insights into Japan medical device testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account